IQVIA Holdings Inc (IQV):企業の財務・戦略的SWOT分析

◆英語タイトル:IQVIA Holdings Inc (IQV) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C13541
◆発行会社(調査会社):GlobalData
◆発行日:2019年2月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

IQVIA Holdings Inc (IQV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to healthcare companies. The company offers a wide range of solutions in clinical development, commercialization and technologies, and helps stimulate significant healthcare outcomes. Its IQVIA CORE is a customized solution that provides actionable insights through big data, transformative technology and analytics with wide industry knowledge in diseases, regions, human behaviors and scientific advances. IQVIA serves biotech, medical device and pharmaceutical companies; medical researchers, government agencies, patient associations, payers and investigators, among others. The company has operations in Asia, Europe, the Americas, the Middle East and Africa. IQVIA is headquartered in Durham, North Carolina, the US.

IQVIA Holdings Inc Key Recent Developments

Feb 04,2019: IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry
Jan 31,2019: IQVIA Launches Next Generation Site Portal Technology Capabilities to Streamline Clinical Trial …
Jan 30,2019: IQVIA to Announce Fourth-Quarter and Full-Year 2018 Results and Issue 2019 Guidance on February 14, 2019
Jan 19,2019: Iqvia launches new division to support emerging biotech market

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
IQVIA Holdings Inc – Key Facts
IQVIA Holdings Inc – Key Employees
IQVIA Holdings Inc – Key Employee Biographies
IQVIA Holdings Inc – Major Products and Services
IQVIA Holdings Inc – History
IQVIA Holdings Inc – Company Statement
IQVIA Holdings Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
IQVIA Holdings Inc – Business Description
Business Segment: Commercial Solutions
Overview
Performance
Business Segment: Integrated Engagement Services
Overview
Performance
Business Segment: Research & Development Solutions
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Europe and Africa
Performance
IQVIA Holdings Inc – Corporate Strategy
IQVIA Holdings Inc – SWOT Analysis
SWOT Analysis – Overview
IQVIA Holdings Inc – Strengths
IQVIA Holdings Inc – Weaknesses
IQVIA Holdings Inc – Opportunities
IQVIA Holdings Inc – Threats
IQVIA Holdings Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
IQVIA Holdings Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 04, 2019: IQVIA Launches IQVIA Biotech, Dedicated to Emerging Biotech and Biopharma Industry
Feb 04, 2019: IQVIA launches IQVIA Biotech, dedicated to emerging biotech and biopharma industry
Jan 30, 2019: IQVIA to Announce Fourth-Quarter and Full-Year 2018 Results and Issue 2019 Guidance on February 14, 2019
Dec 06, 2018: IQVIA Named Best Contract Research Organization Full-Service Provider in 2018 Scrip Awards
Nov 29, 2018: IQVIA s OCE Technology Platform Selected by Napo Pharmaceuticals to Increase Commercial Efficiency
Nov 27, 2018: IQVIA s orchestrated customer engagement selected by Novo Nordisk international operations
Nov 27, 2018: IQVIAs orchestrated customer engagement selected by Novo Nordisk international operations
Nov 20, 2018: Adhera Therapeutics selects IQVIA’s OCE technology platform to support commercial excellence
Oct 30, 2018: Public Release: 30-Oct-2018 Life-changing intersection between big data and therapeutic pipeline in neuromuscular disease MWW Group A new report funded by the Muscular Dystrophy Association (MDA) and released by the IQVIA Institute for Human Data Science
Oct 18, 2018: Xeloda Adherence Support App Contributes to Improving Communication between Cancer Patients and Healthcare Providers
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
IQVIA Holdings Inc, Key Facts
IQVIA Holdings Inc, Key Employees
IQVIA Holdings Inc, Key Employee Biographies
IQVIA Holdings Inc, Major Products and Services
IQVIA Holdings Inc, History
IQVIA Holdings Inc, Other Locations
IQVIA Holdings Inc, Subsidiaries
IQVIA Holdings Inc, Joint Venture
IQVIA Holdings Inc, Key Competitors
IQVIA Holdings Inc, Ratios based on current share price
IQVIA Holdings Inc, Annual Ratios
IQVIA Holdings Inc, Annual Ratios (Cont...1)
IQVIA Holdings Inc, Annual Ratios (Cont...2)
IQVIA Holdings Inc, Interim Ratios
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
IQVIA Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
IQVIA Holdings Inc, Performance Chart (2013 - 2017)
IQVIA Holdings Inc, Ratio Charts
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
IQVIA Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[IQVIA Holdings Inc (IQV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MenoGeniX Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary MenoGeniX Inc (MenoGeniX) is a biopharmaceutical company that develops treatment for menopausal women and cancer patients. The company provides pipeline products portfolio such as MNGX-100, is under Phase 1b human clinical trial. Its therapeutic agents are developed for new indications such …
  • Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Teco Energy Inc:電力:M&Aディール及び事業提携情報
    Summary TECO Energy Inc (TECO), a subsidiary of Emera Inc., is an energy holding company for regulated electricity and gas utilities and other businesses. It generates, transmits, distributes, purchases and sells electricity; and purchases, distributes and sells natural gas through its subsidiaries. …
  • Nissin Electric Co Ltd (6641):企業の財務・戦略的SWOT分析
    Nissin Electric Co Ltd (6641) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Advocate Health Care:製薬・医療:M&Aディール及び事業提携情報
    Summary Advocate Health Care (Advocate Health) is a nonprofit health system that provides health care services. It provides health care services such as inpatient acute and non-acute care, primary and specialty physician services and various outpatient services to communities in Illinois. The organi …
  • Senex Energy Ltd (SXY):企業の財務・戦略的SWOT分析
    Summary Senex Energy Ltd (Senex) is an independent upstream oil and gas company. It mainly focuses on the east coast of Australia. The company acquires, explores, and develops oil and gas assets in the Surat and Cooper basins. It owns significant acreage in the basins with operatorship over all of i …
  • Dynemic Products Ltd.:企業の戦略・SWOT・財務情報
    Dynemic Products Ltd. - Strategy, SWOT and Corporate Finance Report Summary Dynemic Products Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Uptake Medical Corp-製薬・医療分野:企業M&A・提携分析
    Summary Uptake Medical Corp (Uptake Med) is a healthcare technology company that develops medical technologies for the treatment of emphysema and lung cancer. The company develops intervapor therapy system, a bronchoscopic procedure in which heated water vapor is delivered to emphysematous lung tiss …
  • Genuine Parts Company (GPC):企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Liberty Media Corp (BATRA):企業の財務・戦略的SWOT分析
    Liberty Media Corp (BATRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Pierrel Spa (PRL):企業の財務・戦略的SWOT分析
    Pierrel Spa (PRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Geron Corp (GERN):企業の財務・戦略的SWOT分析
    Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Novartis AG (NOVN)-製薬・医療分野:企業M&A・提携分析
    Summary Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, n …
  • Take-Two Interactive Software, Inc.:企業の戦略・SWOT・財務分析
    Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Maruho Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Maruho Co Ltd (Maruho) is a pharmaceutical company that carries out the research, development, production, and distribution of dermatological products. It product portfolio includes a wide range of prescription drugs, medical devices and other skincare products. The company also offers produ …
  • Recordati S.p.A.:企業の戦略・SWOT・財務分析
    Recordati S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Recordati S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SPI Pharma Inc:企業の戦略的SWOT分析
    SPI Pharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • TerniEnergia SpA (TER):企業の財務・戦略的SWOT分析
    Summary TerniEnergia SpA (TerniEnergia), a subsidiary of Terni Research SpA is a renewable energy company that offers energy efficiency, renewable energy, waste, and energy management solutions. The company offers environmental and waste to energy, recovery of materials and development and productio …
  • National Aerospace Fasteners Corporation:企業の戦略・SWOT・財務情報
    National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report Summary National Aerospace Fasteners Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Lung Biotechnology PBC:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Biotechnology PBC (LBI), formerly Lung Biotechnology Inc, is a subsidiary of United Therapeutics Corp, is a biotechnology company that develops and commercializes new therapies for the treatment of PAH and other fatal lung diseases. The company provides product such as Adcirca and Tyvas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆